Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
Siskind D, Friend N, Russell A, McGrath JJ, Lim C, Patterson S, Flaws D, Stedman T, Moudgil V, Sardinha S, Suetani S, Kisely S, Winckel K, Baker A. Siskind D, et al. Among authors: moudgil v. BMJ Open. 2018 Mar 2;8(3):e021000. doi: 10.1136/bmjopen-2017-021000. BMJ Open. 2018. PMID: 29500217 Free PMC article. Clinical Trial.
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine.
Siskind D, Russell AW, Suetani S, Flaws D, Kisely S, Moudgil V, Northwood K, Robinson G, Scott JG, Stedman T, Warren N, Winckel K, Cosgrove P, Baker A. Siskind D, et al. Among authors: moudgil v. Ther Adv Psychopharmacol. 2021 Oct 16;11:20451253211045248. doi: 10.1177/20451253211045248. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34671454 Free PMC article.
Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.
Baker A, Clarke L, Donovan P, P J Ungerer J, Hartel G, Bruxner G, Cocchi L, Gordon A, Moudgil V, Robinson G, Roy D, Sohal R, Whittle E, Scott JG. Baker A, et al. Among authors: moudgil v. Trials. 2021 Dec 13;22(1):918. doi: 10.1186/s13063-021-05890-6. Trials. 2021. PMID: 34903265 Free PMC article.
Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia.
Siskind D, Bull C, Suetani S, Warren N, Suraev A, McGregor I, Kisely S, De Monte V, Trott M, Shine M, Moudgil V, Robinson G, Parker S, Krishnaiah R, Stedman T, Drummond A, Medland S, Iyer R, Baker A. Siskind D, et al. Among authors: moudgil v. BJPsych Open. 2024 Oct 3;10(5):e156. doi: 10.1192/bjo.2024.748. BJPsych Open. 2024. PMID: 39359160 Free PMC article.
98 results